Lucas Donigian
About Lucas Donigian
Lucas Donigian Biography
Lucas Donigian holds the position of Vice President, Business & Commercial Development at Zymeworks. With over 15 years of experience in the biotechnology and biopharma industry, Lucas brings considerable expertise in drug development and diagnostics. He joined the Business Development group at Zymeworks in March 2020. His career trajectory includes prominent roles such as Director of Business Development and BioPharma collaborations at NanoString Technologies as well as serving as a Corporate Development consultant with Dendreon.
Lucas Donigian Education and Expertise
Lucas Donigian received his undergraduate degree in Molecular Biology and Organic Chemistry from San Jose State University. He furthered his academic credentials with an MBA from the University of Washington. His educational background provides a strong foundation for his work in business development within the biotechnology and biopharma sectors.
Lucas Donigian at Zymeworks
Since joining Zymeworks in March 2020, Lucas Donigian has played a crucial role in the Business Development group. As the Vice President of Business & Commercial Development, he leverages his extensive industry experience to drive commercial strategies and foster partnerships, contributing to the company's growth and innovation in drug development.
Lucas Donigian Career Path
Lucas Donigian began his career at OncoMed Pharmaceuticals, where he was involved in developing novel cancer stem cell therapeutics and played a part in bringing multiple therapeutic candidates into early-phase clinical trials. He later moved on to roles with increasing responsibility, including Corporate Development consultant at Dendreon and Director of Business Development and BioPharma collaborations at NanoString Technologies. These roles have equipped him with a broad range of skills in corporate and business development within the biotech industry.
Lucas Donigian Industry Experience
With over 15 years in the biotechnology and biopharma industry, Lucas Donigian's expertise spans drug development, diagnostics, and commercialization of therapeutic strategies. His hands-on experience in both the development of therapeutic candidates and in shaping business strategies makes him a significant asset to any organization within the biotech sector.